We indeed found that ephrin-A3 overexpressed in lung cancer cells can inhibit EphA2 and EphA3 activation by ephrins in trans while overexpression of ephrin-B2 can inhibit activation of EphA3 and EphB4. Here, EPHA2 is linked to lung cancer.